Please login to the form below

Not currently logged in
Email:
Password:

Parsabiv

This page shows the latest Parsabiv news and features for those working in and with pharma, biotech and healthcare.

Amgen’s R&D chief Sean Harper retires to seek biotech post

Amgen’s R&D chief Sean Harper retires to seek biotech post

Bradway said two new products – Aimovig (erenumab) for migraine and Sensipar follow-up Parsabiv (etelcalcetide) for chronic kidney disease – had started well, and the quarter was also marked by the launch ... Parsabiv meanwhile made $73m after making

Latest news

  • NICE set to back Parsabiv for kidney disease complication NICE set to back Parsabiv for kidney disease complication

    NICE set to back Parsabiv for kidney disease complication. Draft guidance recommends Amgen treatment for secondary hyperparathyroidism. ... Parsabiv was approved by the EMA last November and according to the company has advantages over its older drug.

  • Amgen's chronic kidney disease drug Parsabiv cleared in US Amgen's chronic kidney disease drug Parsabiv cleared in US

    Amgen's chronic kidney disease drug Parsabiv cleared in US. Sensipar follow-up is the first therapy to be approved for treatment of sHPT in 12 years. ... to be used in clinical practice, the monthly costs of Parsabiv and Sensipar should be comparable.".

  • Amgen wins European approval for Parsabiv Amgen wins European approval for Parsabiv

    Amgen wins European approval for Parsabiv. Follows FDA knock-back in August for the chronic kidney disease treatment. ... In contrast, Parsabiv is administered as an infusion during dialysis, side-stepping the compliance issue.

  • FDA knocks back Amgen's chronic kidney disease treatment FDA knocks back Amgen's chronic kidney disease treatment

    FDA knocks back Amgen's chronic kidney disease treatment. Parsabiv was hoped to equal or exceed solid earner Sensipar. ... In contrast, Parsabiv is administered as an infusion during dialysis, side-stepping the compliance issue.

More from news
Approximately 4 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics